Skip to main content
. 2016 Feb 10;7(1):87–97. doi: 10.5306/wjco.v7.i1.87

Table 5.

Pharmacological management of chemotherapy extravasation

Dexrazoxane as an antidote to anthracyclines extravasation has level III-B evidence[16]
Hyaluronidaseas an antidote to vinca-alkaloids and to taxanes extravasation has level V-C evidence[16]
Topical DMSO (99%) as an antidote to anthracycline extravasation and to Mytomicin C has level IV-B evidence[16]
Sodium thiosulfate as an antidote to mechlorethamine extravasation has level V-C evidence[16]

DMSO: Dimethyl sulfoxide.